NCT00328939View on ClinicalTrials.gov

ARIXTRA Local Study For Registration In China.

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 31, 2004

Conditions
ThromboembolismKnee ReplacementHip Replacement
Interventions
DRUG

ARIXTRA infusion

DRUG

Enoxaparine infusion

Trial Locations (7)

100044

GSK Investigational Site, Beijing

200025

GSK Investigational Site, Shanghai

266001

GSK Investigational Site, Qingdao

310009

GSK Investigational Site, Hangzhou

450052

GSK Investigational Site, Zhengzhou

610041

GSK Investigational Site, Chengdu

710032

GSK Investigational Site, Xi'an

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY